Margot Morssinkhof

Chapter 3 92 Foster Skewis, L., Bretherton, I., Leemaqz, S. Y., Zajac, J. D., & Cheung, A. S. (2021). Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study. Frontiers in Endocrinology, 12. https://www.frontiersin.org/articles/10.3389/fendo.2021.717766 Frokjaer, V. G. (2020). Pharmacological sex hormone manipulation as a risk model for depression. Journal of Neuroscience Research, 98(7), 1283-1292. https://doi.org/10.1002/ jnr.24632 Gómez-Gil, E., Zubiaurre-Elorza, L., Esteva, I., Guillamon, A., Godás, T., Cruz Almaraz, M., Halperin, I., & Salamero, M. (2012). Hormone-treated transsexuals report less social distress, anxiety and depression. Psychoneuroendocrinology, 37(5), 662-670. https://doi.org/10.1016/j.psyneuen.2011.08.010 Gorin-Lazard, A., Baumstarck, K., Boyer, L., Maquigneau, A., Gebleux, S., Penochet, J.-C., Pringuey, D., Albarel, F., Morange, I., Loundou, A., Berbis, J., Auquier, P., Lançon, C., & Bonierbale, M. (2012). Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study. The Journal of Sexual Medicine, 9(2), 531-541. https://doi.org/10.1111/j.1743-6109.2011.02564.x Heylens, G., Elaut, E., Kreukels, B. P. C., Paap, M. C. S., Cerwenka, S., Richter-Appelt, H., CohenKettenis, P. T., Haraldsen, I. R., & De Cuypere, G. (2014). Psychiatric characteristics in transsexual individuals: Multicentre study in four European countries. British Journal of Psychiatry, 204(2), 151-156. https://doi.org/10.1192/bjp.bp.112.121954 Khan, A. Y., Carrithers, J., Preskorn, S. H., Lear, R., Wisniewski, S. R., John Rush, A., Stegman, D., Kelley, C., Kreiner, K., Nierenberg, A. A., & Fava, M. (2006). Clinical and Demographic Factors Associated With DSM-IV Melancholic Depression. Annals of Clinical Psychiatry, 18(2), 91-98. https://doi.org/10.3109/10401230600614496 Kiyar, M., Kubre, M.-A., Collet, S., Van Den Eynde, T., T’Sjoen, G., Guillamon, A., & Mueller, S. C. (2022). Gender-affirming hormonal treatment changes neural processing of emotions in trans men: An fMRI study. Psychoneuroendocrinology, 146, 105928. https://doi.org/10.1016/ j.psyneuen.2022.105928 Kranz, G. S., Spies, M., Vraka, C., Kaufmann, U., Klebermass, E.-M., Handschuh, P. A., Ozenil, M., Murgaš, M., Pichler, V., Rischka, L., Nics, L., Konadu, M. E., Ibeschitz, H., Traub-Weidinger, T., Wadsak, W., Hahn, A., Hacker, M., & Lanzenberger, R. (2021). High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary report. Psychoneuroendocrinology, 133, 105381. https://doi.org/10.1016/j.psyneuen.2021.105381 Kranz, G. S., Wadsak, W., Kaufmann, U., Savli, M., Baldinger, P., Gryglewski, G., Haeusler, D., Spies, M., Mitterhauser, M., Kasper, S., & Lanzenberger, R. (2015). High-dose testosterone treatment increases serotonin transporter binding in transgender people. Biological Psychiatry, 78(8), 525-533. https://doi.org/10.1016/j.biopsych.2014.09.010 Kuehner, C. (2003). Gender differences in unipolar depression: An update of epidemiological findings and possible explanations. Acta Psychiatrica Scandinavica, 108(3), 163-174. https://doi.org/10.1034/j.1600-0447.2003.00204.x Kuznetsova, A., Brockhoff, P. B., & Christensen, R. H. B. (2017). lmerTest Package: Tests in Linear Mixed Effects Models. Journal of Statistical Software, 83(13), 1-26. https://doi.org/10.18637/ jss.v082.i13 Marcus, S. M., Young, E. A., Kerber, K. B., Kornstein, S., Farabaugh, A. H., Mitchell, J., Wisniewski, S. R., Balasubramani, G. K., Trivedi, M. H., & Rush, A. J. (2005). Gender differences in depression: Findings from the STAR*D study. Journal of Affective Disorders, 87(2), 141-150. https://doi.org/10.1016/j.jad.2004.09.008 Matthys, I., Defreyne, J., Elaut, E., Fisher, A. D., Kreukels, B. P. C., Staphorsius, A., Den Heijer, M., & T’Sjoen, G. (2021). Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI). Journal of Clinical Medicine, 10(2), 296. https://doi.org/10.3390/ jcm10020296

RkJQdWJsaXNoZXIy MTk4NDMw